صراط عشق صراط عشق
Pfizer Inc said its experimental coronavirus vaccine is more than 90-percent effective in protecting people from transmission of the virus in global trials.
Pfizer and German partner BioNTech SE are the first drugmakers to release successful data from a large-scale clinical trial of a coronavirus vaccine. The companies said they have so far found no serious safety concerns and expect to seek US authorisation this month for emergency use of the vaccine for people aged 16 to 85, AlJazeera reported.
“Today is a great day for science and humanity. The first set of results from our phase 3 Covid-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent Covid-19,” said Dr Albert Bourla, the Pfizer chairman and chief executive.
Manufacturing is already under way. Pfizer said they expect to supply globally up to 50m vaccine doses in 2020 and up to 1.3bn doses in 2021, according to The Guardian.
